GH1 and breast cancer: The autocrine hGH-stimulated EMT phenotypic conversion in breast cancer cells was reported to be partially mediated by signal transducer and activator of transcription 3 (STAT3) activation [13], which also mediated the oncogenicity of autocrine hGH in endometrial cancer cells [15].